_id
69185cb63c536f8df2317cb8
Ticker
0QKQ.LSE
Name
RELIEF THERAPEUTICS Holding AG
Exchange
LSE
Address
Chemin de Roseneck 5, Lausanne, Switzerland, 1006
Country
UK
Sector
Industry
Currency
GBP
Website
https://www.relieftherapeutics.com
Description
NeuroX Group SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. The company was incorporated in 2025 and is based in Lausanne, Switzerland.
Last Close
1.9517908800000001
Volume
1997
Current Price
1.644
Change
-6.057692307692313
Last Updated
2025-12-29T14:36:08.999Z
Image
https://logo.clearbit.com/www.relieftherapeutics.com
Ipo Date
-
Market Cap
1432720256
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
1218000
Cost Of Revenue
599000
Gross Profit
619000
Operating Expenses
5044000
Operating Income
-4688000
Interest Expense
24000
Pretax Income
-4504000
Net Income
-4478000
Eps
-0.35673867243184404
Dividends Per Share
-
Shares Outstanding
633947008
Income Tax Expense
26000
EBITDA
-4015000
Operating Margin
-384.8932676518884
Total Other Income Expense Net
184000
Cash
12500000
Short Term Investments
-
Receivables
1468000
Inventories
923000
Total Current Assets
15189000
Property Plant Equipment
2110000
Total Assets
47987000
Payables
620000
Short Term Debt
369000
Long Term Debt
-
Total Liabilities
15354000
Equity
32633000
Bs_currency_symbol
-
Depreciation
747000
Change In Working Capital
789000
Cash From Operations
-3760000
Capital Expenditures
12000
Cash From Investing
1288000
Cash From Financing
-57000
Net Change In Cash
-2580000
Cf_currency_symbol
-
PE
-
PB
0.6323808495694543
ROE
-13.722305641528514
ROA
-9.331694000458457
FCF
-3772000
Fcf Percent
-3.09688013136289
Piotroski FScore
1
Health Score
34
Deep Value Investing Score
4.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
3.5
Net Net Investing Score
2.5
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
1218000
Quarters > 0 > income Statement > cost Of Revenue
599000
Quarters > 0 > income Statement > gross Profit
619000
Quarters > 0 > income Statement > operating Expenses
5044000
Quarters > 0 > income Statement > operating Income
-4688000
Quarters > 0 > income Statement > interest Expense
24000
Quarters > 0 > income Statement > pretax Income
-4504000
Quarters > 0 > income Statement > net Income
-4478000
Quarters > 0 > income Statement > eps
-0.35673867243184404
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
12552606
Quarters > 0 > income Statement > income Tax Expense
26000
Quarters > 0 > income Statement > EBITDA
-4015000
Quarters > 0 > income Statement > operating Margin
-384.8932676518884
Quarters > 0 > income Statement > total Other Income Expense Net
184000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
12500000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1468000
Quarters > 0 > balance Sheet > inventories
923000
Quarters > 0 > balance Sheet > total Current Assets
15189000
Quarters > 0 > balance Sheet > property Plant Equipment
2110000
Quarters > 0 > balance Sheet > total Assets
47987000
Quarters > 0 > balance Sheet > payables
620000
Quarters > 0 > balance Sheet > short Term Debt
369000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
15354000
Quarters > 0 > balance Sheet > equity
32633000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-4478000
Quarters > 0 > cash Flow > depreciation
747000
Quarters > 0 > cash Flow > change In Working Capital
789000
Quarters > 0 > cash Flow > cash From Operations
-3760000
Quarters > 0 > cash Flow > capital Expenditures
12000
Quarters > 0 > cash Flow > cash From Investing
1288000
Quarters > 0 > cash Flow > cash From Financing
-57000
Quarters > 0 > cash Flow > net Change In Cash
-2580000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.35673867243184404
Quarters > 0 > ratios > PB
0.6323808495694543
Quarters > 0 > ratios > ROE
-13.722305641528514
Quarters > 0 > ratios > ROA
-9.331694000458457
Quarters > 0 > ratios > FCF
-3772000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-3.09688013136289
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
2836000
Quarters > 1 > income Statement > cost Of Revenue
4632000
Quarters > 1 > income Statement > gross Profit
-1796000
Quarters > 1 > income Statement > operating Expenses
1822000
Quarters > 1 > income Statement > operating Income
-3618000
Quarters > 1 > income Statement > interest Expense
28000
Quarters > 1 > income Statement > pretax Income
-15359000
Quarters > 1 > income Statement > net Income
-12562000
Quarters > 1 > income Statement > eps
-1.0017543859649123
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
12540000
Quarters > 1 > income Statement > income Tax Expense
-2797000
Quarters > 1 > income Statement > EBITDA
-14208000
Quarters > 1 > income Statement > operating Margin
-127.574047954866
Quarters > 1 > income Statement > total Other Income Expense Net
-11741000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
15080000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
2029000
Quarters > 1 > balance Sheet > inventories
1042000
Quarters > 1 > balance Sheet > total Current Assets
19688000
Quarters > 1 > balance Sheet > property Plant Equipment
2396000
Quarters > 1 > balance Sheet > total Assets
53224000
Quarters > 1 > balance Sheet > payables
1627000
Quarters > 1 > balance Sheet > short Term Debt
960000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
16560000
Quarters > 1 > balance Sheet > equity
36664000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-12562000
Quarters > 1 > cash Flow > depreciation
1123000
Quarters > 1 > cash Flow > change In Working Capital
3077000
Quarters > 1 > cash Flow > cash From Operations
359000
Quarters > 1 > cash Flow > capital Expenditures
14000
Quarters > 1 > cash Flow > cash From Investing
4299000
Quarters > 1 > cash Flow > cash From Financing
-246000
Quarters > 1 > cash Flow > net Change In Cash
4352000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-1.0017543859649123
Quarters > 1 > ratios > PB
0.5622888937377264
Quarters > 1 > ratios > ROE
-34.262491817586735
Quarters > 1 > ratios > ROA
-23.602134375469713
Quarters > 1 > ratios > FCF
345000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.12165021156558534
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
5581000
Quarters > 2 > income Statement > cost Of Revenue
6484000
Quarters > 2 > income Statement > gross Profit
-903000
Quarters > 2 > income Statement > operating Expenses
3148000
Quarters > 2 > income Statement > operating Income
-4051000
Quarters > 2 > income Statement > interest Expense
41000
Quarters > 2 > income Statement > pretax Income
-3997000
Quarters > 2 > income Statement > net Income
-4557000
Quarters > 2 > income Statement > eps
-0.3633971291866029
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
12540000
Quarters > 2 > income Statement > income Tax Expense
560000
Quarters > 2 > income Statement > EBITDA
-2518000
Quarters > 2 > income Statement > operating Margin
-72.58555814370185
Quarters > 2 > income Statement > total Other Income Expense Net
54000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
10728000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
2937000
Quarters > 2 > balance Sheet > inventories
374000
Quarters > 2 > balance Sheet > total Current Assets
14711000
Quarters > 2 > balance Sheet > property Plant Equipment
2701000
Quarters > 2 > balance Sheet > total Assets
70921000
Quarters > 2 > balance Sheet > payables
1291000
Quarters > 2 > balance Sheet > short Term Debt
398000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
21654000
Quarters > 2 > balance Sheet > equity
49267000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-4557000
Quarters > 2 > cash Flow > depreciation
1438000
Quarters > 2 > cash Flow > change In Working Capital
-398000
Quarters > 2 > cash Flow > cash From Operations
-3087000
Quarters > 2 > cash Flow > capital Expenditures
86000
Quarters > 2 > cash Flow > cash From Investing
-86000
Quarters > 2 > cash Flow > cash From Financing
-616000
Quarters > 2 > cash Flow > net Change In Cash
-3828000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.3633971291866029
Quarters > 2 > ratios > PB
0.41844967219436946
Quarters > 2 > ratios > ROE
-9.24959912314531
Quarters > 2 > ratios > ROA
-6.425459313884463
Quarters > 2 > ratios > FCF
-3173000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.5685361046407453
Quarters > 2 > health Score
34
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
3010000
Quarters > 3 > income Statement > cost Of Revenue
8150000
Quarters > 3 > income Statement > gross Profit
-5140000
Quarters > 3 > income Statement > operating Expenses
3118000
Quarters > 3 > income Statement > operating Income
-8258000
Quarters > 3 > income Statement > interest Expense
75000
Quarters > 3 > income Statement > pretax Income
-47542000
Quarters > 3 > income Statement > net Income
-41682000
Quarters > 3 > income Statement > eps
-3.3239234449760766
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
12540000
Quarters > 3 > income Statement > income Tax Expense
-5860000
Quarters > 3 > income Statement > EBITDA
-45853000
Quarters > 3 > income Statement > operating Margin
-274.3521594684385
Quarters > 3 > income Statement > total Other Income Expense Net
-39284000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
14556000
Quarters > 3 > balance Sheet > short Term Investments
9000
Quarters > 3 > balance Sheet > receivables
2837000
Quarters > 3 > balance Sheet > inventories
557000
Quarters > 3 > balance Sheet > total Current Assets
18304000
Quarters > 3 > balance Sheet > property Plant Equipment
2967000
Quarters > 3 > balance Sheet > total Assets
76390000
Quarters > 3 > balance Sheet > payables
1025000
Quarters > 3 > balance Sheet > short Term Debt
2216000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
24162000
Quarters > 3 > balance Sheet > equity
52228000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-41682000
Quarters > 3 > cash Flow > depreciation
1614000
Quarters > 3 > cash Flow > change In Working Capital
-47000
Quarters > 3 > cash Flow > cash From Operations
-7053000
Quarters > 3 > cash Flow > capital Expenditures
77000
Quarters > 3 > cash Flow > cash From Investing
8822000
Quarters > 3 > cash Flow > cash From Financing
-124000
Quarters > 3 > cash Flow > net Change In Cash
1764000
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
-3.3239234449760766
Quarters > 3 > ratios > PB
0.39472620050547597
Quarters > 3 > ratios > ROE
-79.80776594929922
Quarters > 3 > ratios > ROA
-54.56473360387485
Quarters > 3 > ratios > FCF
-7130000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-2.3687707641196014
Quarters > 3 > health Score
34
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
8417000
Annuals > 0 > income Statement > cost Of Revenue
2575000
Annuals > 0 > income Statement > gross Profit
5842000
Annuals > 0 > income Statement > operating Expenses
24727000
Annuals > 0 > income Statement > operating Income
-18885000
Annuals > 0 > income Statement > interest Expense
69000
Annuals > 0 > income Statement > pretax Income
-19356000
Annuals > 0 > income Statement > net Income
-17119000
Annuals > 0 > income Statement > eps
-1.3651515151515152
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
12540000
Annuals > 0 > income Statement > income Tax Expense
-2237000
Annuals > 0 > income Statement > EBITDA
-16726000
Annuals > 0 > income Statement > operating Margin
-224.367351788048
Annuals > 0 > income Statement > total Other Income Expense Net
-471000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
15080000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
2029000
Annuals > 0 > balance Sheet > inventories
1042000
Annuals > 0 > balance Sheet > total Current Assets
19688000
Annuals > 0 > balance Sheet > property Plant Equipment
2396000
Annuals > 0 > balance Sheet > total Assets
53224000
Annuals > 0 > balance Sheet > payables
1627000
Annuals > 0 > balance Sheet > short Term Debt
480000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
16560000
Annuals > 0 > balance Sheet > equity
36664000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-17119000
Annuals > 0 > cash Flow > depreciation
2561000
Annuals > 0 > cash Flow > change In Working Capital
2679000
Annuals > 0 > cash Flow > cash From Operations
-2916000
Annuals > 0 > cash Flow > capital Expenditures
172000
Annuals > 0 > cash Flow > cash From Investing
4401000
Annuals > 0 > cash Flow > cash From Financing
-862000
Annuals > 0 > cash Flow > net Change In Cash
524000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-1.3651515151515152
Annuals > 0 > ratios > PB
0.7097016146628846
Annuals > 0 > ratios > ROE
-46.69157756927776
Annuals > 0 > ratios > ROA
-32.16406132571772
Annuals > 0 > ratios > FCF
-3088000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.3668765593441844
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
6033000
Annuals > 1 > income Statement > cost Of Revenue
1920000
Annuals > 1 > income Statement > gross Profit
4113000
Annuals > 1 > income Statement > operating Expenses
114941000
Annuals > 1 > income Statement > operating Income
-110828000
Annuals > 1 > income Statement > interest Expense
164000
Annuals > 1 > income Statement > pretax Income
-111684000
Annuals > 1 > income Statement > net Income
-98181000
Annuals > 1 > income Statement > eps
-8.354407760381212
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
11752000
Annuals > 1 > income Statement > income Tax Expense
-13503000
Annuals > 1 > income Statement > EBITDA
-108036000
Annuals > 1 > income Statement > operating Margin
-1837.029670147522
Annuals > 1 > income Statement > total Other Income Expense Net
-856000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
14556000
Annuals > 1 > balance Sheet > short Term Investments
9000
Annuals > 1 > balance Sheet > receivables
2837000
Annuals > 1 > balance Sheet > inventories
557000
Annuals > 1 > balance Sheet > total Current Assets
18304000
Annuals > 1 > balance Sheet > property Plant Equipment
2967000
Annuals > 1 > balance Sheet > total Assets
76390000
Annuals > 1 > balance Sheet > payables
1025000
Annuals > 1 > balance Sheet > short Term Debt
861000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
24162000
Annuals > 1 > balance Sheet > equity
52228000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-98181000
Annuals > 1 > cash Flow > depreciation
3318000
Annuals > 1 > cash Flow > change In Working Capital
-991000
Annuals > 1 > cash Flow > cash From Operations
-17612000
Annuals > 1 > cash Flow > capital Expenditures
446000
Annuals > 1 > cash Flow > cash From Investing
8695000
Annuals > 1 > cash Flow > cash From Financing
4050000
Annuals > 1 > cash Flow > net Change In Cash
-4681000
Annuals > 1 > cash Flow > currency_symbol
-
Annuals > 1 > ratios > PE
-8.354407760381212
Annuals > 1 > ratios > PB
0.46690281075285295
Annuals > 1 > ratios > ROE
-187.98537183120166
Annuals > 1 > ratios > ROA
-128.5259850765807
Annuals > 1 > ratios > FCF
-18058000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-2.9932040444223436
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
6081000
Annuals > 2 > income Statement > cost Of Revenue
1250000
Annuals > 2 > income Statement > gross Profit
4831000
Annuals > 2 > income Statement > operating Expenses
56871000
Annuals > 2 > income Statement > operating Income
-52040000
Annuals > 2 > income Statement > interest Expense
196000
Annuals > 2 > income Statement > pretax Income
-54316000
Annuals > 2 > income Statement > net Income
-50790000
Annuals > 2 > income Statement > eps
-4.805108798486282
Annuals > 2 > income Statement > dividends Per Share
6807000
Annuals > 2 > income Statement > shares Outstanding
10570000
Annuals > 2 > income Statement > income Tax Expense
-3526000
Annuals > 2 > income Statement > EBITDA
-50260000
Annuals > 2 > income Statement > operating Margin
-855.7802992928794
Annuals > 2 > income Statement > total Other Income Expense Net
-2276000
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
19237000
Annuals > 2 > balance Sheet > short Term Investments
28000
Annuals > 2 > balance Sheet > receivables
2255000
Annuals > 2 > balance Sheet > inventories
227000
Annuals > 2 > balance Sheet > total Current Assets
22583000
Annuals > 2 > balance Sheet > property Plant Equipment
2691000
Annuals > 2 > balance Sheet > total Assets
188798000
Annuals > 2 > balance Sheet > payables
1625000
Annuals > 2 > balance Sheet > short Term Debt
2096000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
43381000
Annuals > 2 > balance Sheet > equity
145417000
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-50790000
Annuals > 2 > cash Flow > depreciation
3860000
Annuals > 2 > cash Flow > change In Working Capital
5592000
Annuals > 2 > cash Flow > cash From Operations
-24108000
Annuals > 2 > cash Flow > capital Expenditures
521000
Annuals > 2 > cash Flow > cash From Investing
-8017000
Annuals > 2 > cash Flow > cash From Financing
6417000
Annuals > 2 > cash Flow > net Change In Cash
-25524000
Annuals > 2 > cash Flow > currency_symbol
GBP
Annuals > 2 > ratios > PE
-4.805108798486282
Annuals > 2 > ratios > PB
0.15082658836312124
Annuals > 2 > ratios > ROE
-34.92714056815915
Annuals > 2 > ratios > ROA
-26.901768027203676
Annuals > 2 > ratios > FCF
-24629000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-4.050156224305213
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
3321000
Annuals > 3 > income Statement > cost Of Revenue
11907000
Annuals > 3 > income Statement > gross Profit
-8586000
Annuals > 3 > income Statement > operating Expenses
36877000
Annuals > 3 > income Statement > operating Income
-34306000
Annuals > 3 > income Statement > interest Expense
268000
Annuals > 3 > income Statement > pretax Income
-35525000
Annuals > 3 > income Statement > net Income
-34705000
Annuals > 3 > income Statement > eps
-3.8634086608037403
Annuals > 3 > income Statement > dividends Per Share
67689000
Annuals > 3 > income Statement > shares Outstanding
8983000
Annuals > 3 > income Statement > income Tax Expense
-820000
Annuals > 3 > income Statement > EBITDA
-32692000
Annuals > 3 > income Statement > operating Margin
-1033.0021077988558
Annuals > 3 > income Statement > total Other Income Expense Net
-1219000
Annuals > 3 > income Statement > currency_symbol
GBP
Annuals > 3 > balance Sheet > cash
44761000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
2746000
Annuals > 3 > balance Sheet > inventories
391000
Annuals > 3 > balance Sheet > total Current Assets
54970000
Annuals > 3 > balance Sheet > property Plant Equipment
2536000
Annuals > 3 > balance Sheet > total Assets
251618000
Annuals > 3 > balance Sheet > payables
1700000
Annuals > 3 > balance Sheet > short Term Debt
1676000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
70088000
Annuals > 3 > balance Sheet > equity
181530000
Annuals > 3 > balance Sheet > currency_symbol
GBP
Annuals > 3 > cash Flow > net Income
-34705000
Annuals > 3 > cash Flow > depreciation
2036000
Annuals > 3 > cash Flow > change In Working Capital
-5234000
Annuals > 3 > cash Flow > cash From Operations
-35711000
Annuals > 3 > cash Flow > capital Expenditures
13708000
Annuals > 3 > cash Flow > cash From Investing
-30269000
Annuals > 3 > cash Flow > cash From Financing
67689000
Annuals > 3 > cash Flow > net Change In Cash
1607000
Annuals > 3 > cash Flow > currency_symbol
GBP
Annuals > 3 > ratios > PE
-3.8634086608037403
Annuals > 3 > ratios > PB
0.10268123726105878
Annuals > 3 > ratios > ROE
-19.11805211259847
Annuals > 3 > ratios > ROA
-13.79273342924592
Annuals > 3 > ratios > FCF
-49419000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-14.880758807588077
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.35673867243184404
Valuation > metrics > PB
0.6323808495694543
Valuation > final Score
70
Valuation > verdict
36.8% Undervalued
Profitability > metrics > ROE
-13.722305641528514
Profitability > metrics > ROA
-29.48186187372441
Profitability > metrics > Net Margin
-3.676518883415435
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.47050531670395
Risk > metrics > Interest Coverage
-195.33333333333334
Risk > final Score
-721
Risk > verdict
High
Liquidity > metrics > Current Ratio
15.35793731041456
Liquidity > metrics > Quick Ratio
14.424671385237614
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-457
Prev Risks > 1
-335
Prev Risks > 2
-380
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:57:30.510Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-04-08
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-28
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.36
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-10
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.5
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.5
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-03-31
Earnings History > 3 > report Date
2024-04-30
Earnings History > 3 > date
2024-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-3.36
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-3.36
Earnings History > 3 > surprise Percent
-
NeuroX Group SA develops and operates the MindMaze platform that integrates neuroscience and digital therapeutics to address some of the most pressing challenges in neurology. The company was incorporated in 2025 and is based in Lausanne, Switzerland.
Stock Price
£0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of RELIEF THERAPEUTICS Holding AG
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2026-03-31
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.36
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
£ 0
Cost Of Revenue
£ 0
Gross Profit
£ 0
Operating Expenses
£ 0
Operating Income
£ 0
Interest Expense
£ 0
Pretax Income
£ 0
Net Income
£ 0
Income Tax Expense
£ 0
EBITDA
£ 0
Total Other Income Expense Net
£ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
£ 0
Short Term Investments
£ 0
Receivables
£ 0
Inventories
£ 0
Total Current Assets
£ 0
Property Plant Equipment
£ 0
Total Assets
£ 0
Payables
£ 0
Short Term Debt
£ 0
Long Term Debt
£ 0
Total Liabilities
£ 0
Equity
£ 0
(Last Updated 2025-06-30)
Net Income
£ 0
Depreciation
£ 0
Change In Working Capital
£ 0
Cash From Operations
£ 0
Capital Expenditures
£ 0
Cash From Investing
£ 0
Cash From Financing
£ 0
Net Change In Cash
£ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.